Lincoln Pharmaceuticals Limited Recommended a dividend of INR 1.50/- (i.e. 15% per share) per equity share of face value of INR 10/- for the year ended March 31, 2023, for approval of the members at the ensuring annual general meeting (AGM) of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
599 INR | +0.14% | +4.89% | -1.81% |
1st Jan change | Capi. | |
---|---|---|
-1.81% | 144M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- LINCOLN Stock
- News Lincoln Pharmaceuticals Limited
- Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023